Results 121 to 130 of about 247,667 (242)

Might modulation of the endocannabinoid system provide a potential dual therapeutic strategy for osteoporosis and depression?

General Psychiatry, Volume 39, Issue 4, August 2026.
Peng Wei, Pianpian Zhao, Zenghui Gu, Mengyuan Yang, David Karasik, Ching‐Lung Cheung, Houfeng Zheng   +6 more
wiley   +1 more source

Inhibition of peripheral CB1 receptors modulates food intake and metabolic efficiency in obesity independently of the gut–brain vagal axis

British Journal of Pharmacology, Volume 183, Issue 16, Page 4953-4968, August 2026.
Background and Purpose Obesity involves profound disruptions in neuronal circuits, neuroendocrine communication and the endocannabinoid system. While global blockade of cannabinoid CB1 receptors improves metabolism, its clinical use is limited by neuropsychiatric side effects.
Oriane Onimus, Camille de Almeida, Benoit Bertrand, Julien Castel, Nejmeh Mashhour, Anthony Ansoult, Serge Luquet, Giuseppe Gangarossa   +7 more
wiley   +1 more source

Multivalent antibody‐based conjugates as new tools for tailored modulation of G protein–coupled receptors

British Journal of Pharmacology, Volume 183, Issue 16, Page 4512-4531, August 2026.
The G protein–coupled receptor (GPCR) superfamily consists of the most common targets of approved drugs. Targeting GPCRs offers appealing avenues for therapeutic development. Antibodies and their fragments, such as single‐domain antibodies (VHHs or nanobodies), have emerged as useful alternatives to small molecule pharmacophores as building blocks in ...
Shivani Sachdev, Ross W. Cheloha
wiley   +1 more source

Oligonucleotides Post‐Synthetic Modifications: An Overview of Clickable Nucleoside Phosphoramidites Suitable for Solid‐Phase Synthesis

ChemBioChem, Volume 27, Issue 13, 14 July 2026.
Clickable nucleoside phosphoramidites can be incorporated into oligonucleotides via solid‐phase synthesis (SPOS), enabling rapid and site‐specific post‐functionalization using bioorthogonal reactions. This review highlights their design, synthetic accessibility, and SPOS incorporation requirements, along with the kinetics and efficiency of post ...
Sébastien Depienne, Alexandra Bristiel, Dominique Urban, Dominique Guianvarc’h   +3 more
wiley   +1 more source

Acute metabolic effects of cannabinoid receptor modulators during sequential hyperglycemic, euglycemic-hyperinsulinemic clamps in healthy individuals. [PDF]

Am J Physiol Endocrinol Metab
Chia CW, Tang EY, Cutler RG, You SS, Chen Q, Choo AYM, Melvin DL, Ramsden CE, Kapogiannis D, Egan JM.   +9 more
europepmc   +1 more source

Pharmacological Evaluation of Cannabinoid Receptor Modulators Using GRAB_eCB2.0 Sensor. [PDF]

Int J Mol Sci
Shivshankar S, Nimely J, Puhl H, Iyer MR.   +3 more
europepmc   +1 more source

Precision phenotyping of elevated arousal in posttraumatic stress disorder: implications for personalized GABAergic pharmacotherapy. [PDF]

Front Psychiatry
Vasquez VR, Howlett JR.
europepmc   +1 more source

Genetically Encoded CB₂R-Based Fluorescent Sensor Enables Rapid Screening and Functional Assessment of Cannabinoid Modulators. [PDF]

Int J Mol Sci
Bhattacharjee P, Volesky PD, Shivshankar S, Puhl H, Iyer MR.   +4 more
europepmc   +1 more source

Cannabinoids in Alzheimer's disease: animal-human evidence and clinical pharmacology challenges. [PDF]

Front Behav Neurosci
Komedera M, Wojda U, Kiryk A.
europepmc   +1 more source

Targeting Pain and Depression in Alzheimer's Disease: Translational Insights and Emerging Treatments. [PDF]

Pharmaceuticals (Basel)
Costachescu I, Stanciu GD, Gogu RM, Tamba BI.   +3 more
europepmc   +1 more source